• Home
  • News
    • Pre-Meeting
    • Meeting Coverage
    • Post-Meeting
    • Poster Presenters 2024
    • Archives
      • 2023
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
  • Map & Photos
  • Industry
    • Industry Events
      • Featured Industry Events
      • Innovation Theaters
      • Industry-Supported Symposia
      • Lightning Talks
    • Industry Connections
  • Publications
    • Preview Edition Newspaper
    • Meeting Magazine
  • App & Planner
  • Schedule
  • Resources
    • App & Planner
    • Schedule
  • Follow Us
    • X (Twitter)
    • Facebook
    • LinkedIn
    • YouTube
  • Subscribe
Meeting Home

The official news source of ACR Convergence 2024

Watch On Demand
  • Emerging biomarkers may pave the way for precision medicine in lupus

    Emerging biomarkers may pave the way for precision medicine in lupus

    November 12, 2019

    The “holy grail” in the quest to identify and validate new biomarkers, said Jill Buyon, MD, is the hope that biomarkers will aid the clinician in managing the patient, help to sort out phenotypic heterogeneity, inform about pathogenesis, and provide targets for therapy to achieve…

  • Panel explores ethics of precision medicine, genetic testing

    Panel explores ethics of precision medicine, genetic testing

    November 12, 2019

    Researchers and clinicians alike get increasingly excited as science advances and the dream of personalized — and more effective — medicine draws closer to reality. But personalized medicine has ethical considerations and unintended consequences to address.

  • Despite the availability and growing popularity of medical cannabis, more clinical evidence is needed

    Despite the availability and growing popularity of medical cannabis, more clinical evidence is needed

    November 12, 2019

    Patients are turning to cannabis for a variety of uses, especially chronic pain, and report having positive effects from the use. But the clinical evidence available is a “mish-mash of studies,” said Mary-Ann Fitzcharles, MD.

  • Practicing wellness strategies can help physicians avoid burnout, become more content

    Practicing wellness strategies can help physicians avoid burnout, become more content

    November 12, 2019

    A national physician survey found that bureaucratic tasks such as paperwork contributed the most to burnout. That same survey also showed rheumatologists are almost at the bottom of the list of physicians likely to seek help, at 16%.

  • Neutrophil NETs take another Knowledge Bowl title

    Neutrophil NETs take another Knowledge Bowl title

    November 12, 2019

    The team of Jean W. Liew, MD, and Joanna Marco, MD, along with consultant Grant Hughes, MD, from the University of Washington held off the Elbow-Knee team from Albany Medical Center and Joint Service Joint Service from Walter Reed National Medical Military Center.

  • Draft of new clinical guidelines for GCA, TAK, PAN presented at Annual Meeting

    Draft of new clinical guidelines for GCA, TAK, PAN presented at Annual Meeting

    November 11, 2019

    The new guidelines include both “strong” recommendations, which are generally supported by moderate or high-quality evidence, and “conditional” recommendations, which are generally supported by lower-quality evidence.

  • Lupus needs more treatment options, better trial designs

    Lupus needs more treatment options, better trial designs

    November 11, 2019

    Although lupus survival has improved throughout the years, presenters in the Monday session Lupus Treatment: B Cells, Interferon & More emphasized that a serious need remains for new treatments and better trial designs.

  • Plenary II showcases six of the Annual Meeting’s top abstracts

    Plenary II showcases six of the Annual Meeting’s top abstracts

    November 11, 2019

    Showcasing cutting-edge rheumatology research from around the world, six of the top abstracts submitted for this year’s Annual Meeting were presented during Monday’s Plenary II session.

  • FDA provides updates on new drug approvals, indications, and safety issues

    FDA provides updates on new drug approvals, indications, and safety issues

    November 11, 2019

    The FDA approved the first treatment for pediatric patients with lupus, among other products and drugs for new indications and populations, and made several important safety updates in 2019, which were reviewed during an Annual Meeting session on Monday.

  • Innovation will be required to address expected rheumatology workforce shortage

    Innovation will be required to address expected rheumatology workforce shortage

    November 11, 2019

    It’s a time of exciting new treatment discoveries and improved patient outcomes, but it should come as no surprise to rheumatologists that adult rheumatology workforce projections look grim.

Previous Page
1 2 3 4 … 12
Next Page

Upcoming Featured Industry Events

View All

View Archives

  • Select Year
    • 2017
    • 2018
    • 2019
    • 2020
    • 2021
    • 2022
    • 2023

Popular Articles

  • Daltroy Lecture Examines the Psychological Impacts of Living with Rheumatic Disease


  • ARP Distinguished Lecture: Better Understanding of AI Will Enhance Its Utility for Rheumatologists


  • FDA Gives Updates on Newly Approved Agents for Rheumatic Diseases


  • Clinicians Discuss Experience Using Ambient Listening Technology in Clinical Practice


  • Opening Session Keynote Spotlights the Crucial Role of Allyship in Rheumatology



@2024 American College of Rheumatology. All Rights Reserved. Powered by TriStar Event Media, LLC

Privacy Policy